Jeil Pharmaceutical Co.,Ltd (KRX: 271980)
South Korea
· Delayed Price · Currency is KRW
12,900
+430 (3.45%)
Nov 18, 2024, 3:30 PM KST
Jeil Pharmaceutical Co.,Ltd Revenue
Jeil Pharmaceutical Co.,Ltd had revenue of 173.18B KRW in the quarter ending June 30, 2024, a decrease of -2.96%. This brings the company's revenue in the last twelve months to 700.47B, down -2.32% year-over-year. In the year 2023, Jeil Pharmaceutical Co.,Ltd had annual revenue of 726.39B with 0.58% growth.
Revenue (ttm)
700.47B
Revenue Growth
-2.32%
P/S Ratio
0.27
Revenue / Employee
724.37M
Employees
967
Market Cap
187.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 726.39B | 4.16B | 0.58% |
Dec 31, 2022 | 722.23B | 21.54B | 3.07% |
Dec 31, 2021 | 700.69B | 9.37B | 1.36% |
Dec 31, 2020 | 691.32B | 19.92B | 2.97% |
Dec 31, 2019 | 671.41B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition